boehringer ingelheim glp-1 initiates Phase 2 clinical trial of Gubra-originated triple receptor agonist for people living with overweight and obesity 베링거도, 'GLP-1/GCG' 비만 2상 "독성이슈..데자뷰"
Pay in 4 interest-free payments of $7.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
























